[go: up one dir, main page]

KR870007282A - 효모에서 b형 간염 바이러스 단백질을 제조하는 방법 - Google Patents

효모에서 b형 간염 바이러스 단백질을 제조하는 방법

Info

Publication number
KR870007282A
KR870007282A KR1019870000733A KR870000733A KR870007282A KR 870007282 A KR870007282 A KR 870007282A KR 1019870000733 A KR1019870000733 A KR 1019870000733A KR 870000733 A KR870000733 A KR 870000733A KR 870007282 A KR870007282 A KR 870007282A
Authority
KR
South Korea
Prior art keywords
yeast
virus protein
producing hepatitis
hepatitis
producing
Prior art date
Application number
KR1019870000733A
Other languages
English (en)
Other versions
KR940005588B1 (ko
Inventor
더블유. 엘리스 로날드
하고피안 아르피
제이. 크니스케른 피터
Original Assignee
머크 앤드 캄파니, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 머크 앤드 캄파니, 인코포레이티드 filed Critical 머크 앤드 캄파니, 인코포레이티드
Publication of KR870007282A publication Critical patent/KR870007282A/ko
Application granted granted Critical
Publication of KR940005588B1 publication Critical patent/KR940005588B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/223—Hepatitis related

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
KR1019870000733A 1986-01-31 1987-01-20 효모에서 b형 간염 바이러스 단백질을 제조하는 방법 KR940005588B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/824,405 US4816564A (en) 1986-01-31 1986-01-31 Method for producing hepatitis B virus proteins in yeast
US824,405 1986-01-31

Publications (2)

Publication Number Publication Date
KR870007282A true KR870007282A (ko) 1987-08-18
KR940005588B1 KR940005588B1 (ko) 1994-06-21

Family

ID=25241323

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870000733A KR940005588B1 (ko) 1986-01-31 1987-01-20 효모에서 b형 간염 바이러스 단백질을 제조하는 방법

Country Status (7)

Country Link
US (2) US4816564A (ko)
EP (1) EP0244924B1 (ko)
JP (1) JPH0759595B2 (ko)
KR (1) KR940005588B1 (ko)
CN (1) CN1032315C (ko)
DE (1) DE3789399T2 (ko)
PH (1) PH25249A (ko)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158769A (en) * 1984-03-07 1992-10-27 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US5204096A (en) * 1984-03-07 1993-04-20 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US5098704A (en) * 1984-06-18 1992-03-24 Chiron Corporation Hepatitis surface antigen particle vaccine
JPS6137738A (ja) * 1984-07-31 1986-02-22 Tetsuo Nakamura Ｂ型肝炎ワクチン
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
EP0278940A3 (en) * 1987-01-30 1988-12-07 Smithkline Biologicals S.A. Hepatitis b virus surface antigens and hybrid antigens containing them
EP1088830A3 (en) * 1987-06-22 2004-04-07 Medeva Holdings B.V. Hepatitis b surface antigen particles
KR970007153B1 (ko) * 1987-06-22 1997-05-03 메데바 홀딩스 비브이 B형 간염 표면 항원 백신
WO1988010300A1 (en) * 1987-06-22 1988-12-29 Medico Labs Ag Heterologous viral peptide particle immunogens
US4963483A (en) * 1987-10-13 1990-10-16 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
JPH0216975A (ja) * 1988-02-09 1990-01-19 Eugene Tech Internatl Inc 異成分混交性のプレーｓに富んだｂ型肝炎表面抗原
NZ228774A (en) * 1988-04-25 1991-05-28 Phillips Petroleum Co Hbv particles containing pres 2 proteins and recombinant processes for their production in yeast cells
NZ228948A (en) * 1988-05-13 1991-06-25 Phillips Petroleum Co Hbv particles containing s and pre-s 2 proteins and recombinant processes for their production in yeast cells
US5274081A (en) * 1989-09-20 1993-12-28 Immuno A.G. Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
US5576175A (en) * 1989-09-20 1996-11-19 Immuno Aktiengesellschaft Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
JPH06501382A (ja) * 1990-06-15 1994-02-17 エール ユニバーシティ ライム病の予防および診断に用いる組成物および方法
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
WO1992013951A1 (en) * 1991-02-04 1992-08-20 The Salk Institute Biotechnology/Industrial Associates, Inc. Production of human serum albumin in methylotrophic yeast cells
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
IL101651A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Hepatitis b virus surface proteins with reduced host carbohydrate content
US6607727B1 (en) * 1991-08-26 2003-08-19 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
CN1073604A (zh) * 1991-12-01 1993-06-30 高真南 制备高免疫原性乙型肝炎疫苗的方法
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
US6235288B1 (en) * 1992-08-26 2001-05-22 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
DE69433007T2 (de) * 1993-02-26 2004-06-09 The Scripps Research Institute, La Jolla Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
CN1063343C (zh) * 1993-04-27 2001-03-21 中国科学院上海生物化学研究所 氨端带前表面抗原决定簇的乙型肝炎表面抗原蛋白
CN1059927C (zh) * 1994-03-10 2000-12-27 中国科学院上海生物化学研究所 羧端带有前表面抗原1抗原决定簇的乙肝表面抗原融合基因及其编码蛋白
CN1081069C (zh) * 1998-08-14 2002-03-20 饶纬华 乙型肝炎治疗性疫苗及其制备方法
KR100587944B1 (ko) * 2001-05-25 2006-06-08 (주)두비엘 보강제 및 ＨＢＶ 백신 성분인 Ｂ형 간염 바이러스의ｐｒｅ Ｓ단백질
US7964196B2 (en) * 2004-05-25 2011-06-21 Chimeros, Inc. Self-assembling nanoparticle drug delivery system
ATE460922T1 (de) * 2006-04-07 2010-04-15 Chimeros Inc Zusammensetzungen und verfahren zur behandlung von b-zellen-malignomen
AU2008236566A1 (en) * 2007-04-09 2008-10-16 Chimeros, Inc. Self-assembling nanoparticle drug delivery system
WO2010120874A2 (en) 2009-04-14 2010-10-21 Chimeros, Inc. Chimeric therapeutics, compositions, and methods for using same
WO2013036973A2 (en) 2011-09-09 2013-03-14 Biomed Realty, L.P. Methods and compositions for controlling assembly of viral proteins
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4412151A (en) * 1980-09-02 1983-10-25 Charles W. Taggart Piezoelectric crystal spark plug
GR76274B (ko) * 1981-08-04 1984-08-04 Univ California
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
JPS5931799A (ja) * 1982-08-16 1984-02-20 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えプラスミド
US4707542A (en) * 1983-08-22 1987-11-17 Merck & Co., Inc. Immunogenic HbsAg derived from transformed yeast
US4847080A (en) * 1984-03-07 1989-07-11 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
JPS60196185A (ja) * 1984-03-19 1985-10-04 Chemo Sero Therapeut Res Inst 形質転換酵母の培養方法
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
EP0180012A1 (de) * 1984-10-27 1986-05-07 Wolfram H. Prof. Dr. Gerlich Immunogene Polypeptidsequenz des Hepatitis B-Virus
US4683136A (en) * 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants
FI861417A0 (fi) * 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
US4742158A (en) * 1986-04-25 1988-05-03 Merck & Co., Inc. Purification of hepatitis pre-S antigens by polymerized serum albumin affinity binding
US4683293A (en) * 1986-10-20 1987-07-28 Phillips Petroleum Company Purification of pichia produced lipophilic proteins
US4818527A (en) * 1986-12-09 1989-04-04 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
US4778784A (en) * 1987-01-07 1988-10-18 Baylor College Of Medicine Cyclic peptide and method of use for inducing an immunological response to hepatitis B virus

Also Published As

Publication number Publication date
KR940005588B1 (ko) 1994-06-21
PH25249A (en) 1991-03-27
US4816564A (en) 1989-03-28
EP0244924A1 (en) 1987-11-11
JPH0759595B2 (ja) 1995-06-28
JPS62208288A (ja) 1987-09-12
CN87100465A (zh) 1987-10-14
DE3789399T2 (de) 1994-10-06
US5133961A (en) 1992-07-28
DE3789399D1 (de) 1994-04-28
CN1032315C (zh) 1996-07-17
EP0244924B1 (en) 1994-03-23

Similar Documents

Publication Publication Date Title
KR870007282A (ko) 효모에서 b형 간염 바이러스 단백질을 제조하는 방법
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
FI981380L (fi) Menetelmä HCV-polypeptidien valmistamiseksi
LTIP1793A (en) Method for detecting antibodies against hiv virus
FI883783L (fi) Menetelmä nasaalivalmisteiden valmistamiseksi
AT399720B (de) Gewinnung von amphiregulin durch gentechnische verfahren
FI885816L (fi) Menetelmä taikinan parantamiseksi
FI875427L (fi) Menetelmä valmistaa hevosen -interferonia
FI891074L (fi) Menetelmä syklisten sulfaattien valmistamiseksi
DE3777097D1 (de) Herstellungsverfahren von tert.-butylmethacrylat.
FI872769L (fi) Menetelmä alfa-mono-olefiinien polymeroimiseksi
ATA1890A (de) Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
DK398987D0 (da) Fremgangsmaade til fremstilling af blodprotein
FI871522L (fi) Menetelmä proteiinien renaturoimiseksi
DE3579136D1 (de) Verfahren zur herstellung von hochgereinigten, hepatitis-b-virus-infektionsfreien gammaglobulinen.
ZA894182B (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
KR880001562A (ko) 알킬페놀류의 제조방법
KR880701819A (ko) 연료 개량 방법
DK388787A (da) Fremgangsmaade til fremstilling af interferon
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
DE3776164D1 (de) Verfahren zur herstellung von komplexen perovskittypverbindungen.
KR900012650A (ko) 진공 증류 방법
FI891941L (fi) Uttryckande av hepatitis b pres2-protein i metylotropa jaester.
DE3675252D1 (de) Verfahren zur herstellung von cordieritkeramiken.
KR900012649A (ko) 진공 증류 방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19870130

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19911227

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19870130

Comment text: Patent Application

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19940527

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19940831

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19940914

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19940914

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19970410

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19971126

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19990326

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20000316

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20010317

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20020326

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20030417

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20030417

Start annual number: 10

End annual number: 10

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee